HER2 ADC
1 clinical trial
1 abstract
8 indications
Indication
Breast NeoplasmIndication
Breast CancerIndication
Breast TumorsIndication
Triple-Negative Breast CancerIndication
Breast Cancer (HER2-positive)Indication
Hormone Receptor Positive TumorIndication
Hormone Receptor Negative TumorIndication
Locally Advanced Breast CancerClinical trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy (FASCINATE-N)Status: Recruiting, Estimated PCD: 2024-09-01
Abstract
SAVE: A prospective, single-arm, single-center clinical study of disitamab vedotin in combination with toripalimab in patients with advanced penile cancer that has progressed or is intolerant to cisplatin chemotherapy.Org: Affiliated Cancer Hospital of Chongqing University,